Ireland
--:--IST
Recruiting Not applicable

DVT Burden and the Risk of Post-thrombotic Syndrome

NCT06385353 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-06-05
Last updated
2026-07-07

Condition(s) studied

Postthrombotic Syndrome

Investigational drug(s) / intervention(s)

Quantification of deep vein thrombosis burden and assessment of post-thrombotic syndrome

Quantification of deep vein thrombosis burden and assessment of post-thrombotic syndrome: Post-thrombotic syndrome will be assessed by the Villalta score until 6 months of follow-up. Data collected from colour doppler ultrasound will be used to calculate the Venous Volumetric Index to quantify deep vein thrombosis burden until 6 months of follow-up.

Study summary

Post-thrombotic syndrome (PTS) is the most common chronic complication of deep vein thrombosis (DVT), with major consequences for patient quality of life and cost of management. Identifying patients at high risk of developing PTS could be useful for its prevention and may lead to more appropriate therapeutic strategies to reduce its incidence and severity.

Prognostic tools for predicting risk are very useful for choosing the optimum treatment and improving patient management and are a preliminary step before developing predictive models useful for determining sensitivity to treatment. At present, although several prognostic markers and models have been proposed, it is still difficult to predict who will develop a PTS or a moderate to severe PTS. The development of PTS is multifactorial and depends largely on the extent and severity of venous obstruction which supports the theory of thrombosis burden (DVT-Burden) as a potential prognostic marker for PTS. It therefore seems important to study the association between thrombosis burden and the occurrence of PTS.

The Venous Volumetric Index or VVI (Ouriel 1999) will be used for quantifying DVT-Burden. The VVI was constructed by calculating the volume from the diameter and length of 14 venous segments from the calf veins to the inferior vena cava. The VVI has been validated for its ability to discriminate between symptomatic and asymptomatic DVT and has shown superior performance to other methods for quantifying DVT.

This study aim to assess the performance of baseline DVT-burden estimated by the VVI score on ultrasound for predicting the occurrence and the severity of PTS as assessed by the Villalta scale at 6 months.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 18 years 2. Patients with symptomatic acute deep venous thrombosis of the lower limbs confirmed by ultrasound on the criteria of venous incompressibility and direct image of the thrombus (patients with stable pulmonary embolism associated with a symptomatic deep venous thrombosis can be included) 3. Affiliates or beneficiaries of a social security scheme. Exclusion Criteria: 1. Pregnant women, women in labour or breastfeeding mothers. 2. Pulmonary embolism haemodynamically unstable defined by systolic blood pressure \< 90 mmHg or a drop in systolic blood pressure of at least 40 mmHg during at least 15 min, shock or cardiac arrest. 3. Asymptomatic venous thrombosis. 4. Symptomatic venous thrombosis of both lower limbs (patients with bilateral deep venous thrombosis but symptomatic on one side only can be included). 5. History of ipsilateral or contralateral venous thrombosis of the lower limb. 6. Fracture or orthopedic surgery of the lower limbs in the last 3 months. 7. Dependance caused by age or secondary to a chronic affection, going from the inability to stand up or walk alone without help to bed or armchair rest over. 8. Prophylactic or therapeutic anticoagulant treatment \> 5 days. 9. Expected duration of anticoagulant treatment \< 3 months (all patients must have a minimum treatment of 3 months). 10. Patient estimated at high risk of bleeding according to investigator clinical judgment (renal, platelet, digestive, hepatic, neurological... origin) . 11. Indication for interruption of the inferior vena cava or venous recanalisation (endovascular, thrombolysis or surgery). 12. Refusal or inability to give written informed consent to participate in the study. 13. Life expectancy \< 6 months. 14. Patients under legal protection (guardianship, curatorship, etc.) or safeguard of justice. 15. Patients taking part in a research project for venous thromboembolism that can interfere with the conduct of DVT-BURDEN research.

Primary outcome measure(s)

  • Presence of moderate to severe Post-thrombotic Syndrome (PTS) — 6 months
    The primary outcome measure is the presence of moderate or severe PTS at 6 months as determined by a Villalta score ≥ 10 or the presence of an ulcer. The Villalta score considers items based on symptoms and clinical signs, including skin complications, each assessed on a scale from 0 to 3. The Villalta score is used to diagnose PTS and categorise its severity, according to international recommendations. Thrombosis burden is assessed using the VVI index as well as prognostic factors at baseline.
  • Thrombosis burden — Baseline
    Thrombosis burden is assessed using the Venous Volumetric Index (VVI) as well as prognostic factors at baseline.

Trial sites (27)

FacilityCityRegionStatus
CH de Vichy Vichy Allier Recruiting
Centre Hospitalier de Carcassonne Carcassonne Aude Recruiting
Hôpital d'Aubagne Aubagne Bouches-du-Rhône Not Yet Recruiting
Hôpital Saint Joseph Marseille Bouches-du-Rhône Recruiting
Hôpital La Timone, AP-HM Marseille Bouches-du-Rhône Recruiting
Cabinet libéral Martigues Bouches-du-Rhône Terminated
Cabinet libéral Ajaccio Corse-du-sud Recruiting
Cabinet libéral Ajaccio Corse-du-sud Recruiting
CHU de Dijon Dijon Côte d'Or Recruiting
CHU de Besançon Besançon Doubs Recruiting
Centre Hospitalier Universitaire de Brest Brest Finistère Recruiting
Clinique Rive Gauche Toulouse Haut-Garonne Recruiting
CHU de Toulouse Toulouse Haute-Garonne Recruiting
Centre de Santé Polyvalent de UGESSAP Montoir-de-Bretagne Loire-Atlantique Terminated
CHU Saint Etienne Saint-Priest-en-Jarez Pays de la Loire Region Recruiting
Hospices Civils de Lyon, Hôpital Edouard Herriot Lyon Rhône Recruiting
Centre Hospitalier Universitaire Amiens Picardie Amiens Somme Recruiting
Centre Hospitalier de Fréjus/Saint-Raphaël Fréjus Var Terminated
Polyclinique Les Fleurs Ollioules Var Recruiting
Centre cardio-vasculaire Esterel Saint-Raphaël Var Withdrawn
Cabinet libéral Sanary-sur-Mer Var Recruiting
Cabinet libéral Six-Fours-les-Plages Var Recruiting
Centre Hospitalier Intercommunal Toulon La Seyne-sur-Mer Toulon Var Recruiting
Centre Hospitalier d'Avignon Avignon Vaucluse Recruiting
Centre Hospitalier Universitaire de Nantes Nantes France Recruiting
Hôpital Saint Joseph Paris France Recruiting
Hôpital Européen Georges Pompidou Paris France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06385353 on ClinicalTrials.gov ↗ ← All trials in France